021-51111890
购物车（）
sales@molnova.cn
Deferoxamine mesylate
CAS No. 138-14-7
Deferoxamine mesylate ( Desferrioxamine B mesylate;DFOM )
产品货号. M11580 CAS No. 138-14-7
An iron chelator that binds iron and aluminium; increases HIF-1α transactivation in diabetes by preventing iron-catalyzed reactive oxygen stress.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 100MG | ￥405 | 有现货 |
|
| 200MG | 获取报价 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Deferoxamine mesylate
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述An iron chelator that binds iron and aluminium; increases HIF-1α transactivation in diabetes by preventing iron-catalyzed reactive oxygen stress.
-
产品描述An iron chelator that binds iron and aluminium; increases HIF-1α transactivation in diabetes by preventing iron-catalyzed reactive oxygen stress.Other Indication Approved
-
同义词Desferrioxamine B mesylate;DFOM
-
通路Others
-
靶点Other Targets
-
受体Aluminum;Iron
-
研究领域Other Indications
-
适应症Other Disease
化学信息
-
CAS Number138-14-7
-
分子量656.79
-
分子式C26H52N6O11S
-
纯度>98% (HPLC)
-
溶解度H2O: ≥ 33 mg/mL
-
SMILESCS(O)(=O)=O.CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN
-
化学全称Butanediamide, N4-[5-[[4-[[5-(acetylhydroxyamino)pentyl]amino]-1,4-dioxobutyl]hydroxyamino]pentyl]-N1-(5-aminopentyl)-N1-hydroxy-, methanesulfonate (1:1)
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Duscher D, et al. Proc Natl Acad Sci U S A. 2015 Jan 6;112(1):94-9.
2. Miyajima H, et al. Ann Neurol. 1997 Mar;41(3):404-7.
3. Choi EY, et al. J Immunol. 2004 Jun 1;172(11):7069-77.
2. Miyajima H, et al. Ann Neurol. 1997 Mar;41(3):404-7.
3. Choi EY, et al. J Immunol. 2004 Jun 1;172(11):7069-77.
产品手册
关联产品
-
Neuropeptide Y (29-6...
Neuropeptide Y (29-64), amide, human (TFA) is involved in Alzheimer's disease (AD) and protects rat cortical neurons against β-Amyloid toxicity.It is showed that Neuropeptide Y (29-64), amide, human (TFA) is able to protect cortical neurons from Aβ25-35 toxicity.
-
Protein Kinase C (19...
Protein Kinase C (19-31) TFA, a peptide inhibitor of protein kinase C (PKC), derived from the pseudo-substrate regulatory domain of PKCa (residues 19-31) with a serine at position 25 replacing the wild-type alanine, is used as protein kinase C substrate peptide for testing the protein kinase C activity.
-
Methyl nomilinate
Methyl nomilinate from citrus can modulate cell cycle regulators to induce cytotoxicity in human colon cancer (SW480) cells in vitro.
